JP2023520207A5 - - Google Patents
Info
- Publication number
- JP2023520207A5 JP2023520207A5 JP2022559580A JP2022559580A JP2023520207A5 JP 2023520207 A5 JP2023520207 A5 JP 2023520207A5 JP 2022559580 A JP2022559580 A JP 2022559580A JP 2022559580 A JP2022559580 A JP 2022559580A JP 2023520207 A5 JP2023520207 A5 JP 2023520207A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- tautomer
- compound
- ring
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063004713P | 2020-04-03 | 2020-04-03 | |
| US63/004,713 | 2020-04-03 | ||
| PCT/US2021/025591 WO2021203007A1 (en) | 2020-04-03 | 2021-04-02 | Substituted 5-hydroxyindole compounds as modulators of alpha-1 antitrypsin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023520207A JP2023520207A (ja) | 2023-05-16 |
| JP2023520207A5 true JP2023520207A5 (enExample) | 2024-04-10 |
| JP7733670B2 JP7733670B2 (ja) | 2025-09-03 |
Family
ID=76444526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559580A Active JP7733670B2 (ja) | 2020-04-03 | 2021-04-02 | アルファ１－アンチトリプシンのモジュレーター |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230339915A1 (enExample) |
| EP (1) | EP4126817A1 (enExample) |
| JP (1) | JP7733670B2 (enExample) |
| AU (1) | AU2021246104A1 (enExample) |
| CA (1) | CA3177524A1 (enExample) |
| WO (1) | WO2021203007A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3114672A1 (en) | 2018-10-05 | 2020-04-23 | Vertex Pharmaceuticals Incorporated | Modulators of alpha-1 antitrypsin |
| US11884672B2 (en) | 2019-05-14 | 2024-01-30 | Vertex Pharmaceuticals Incorporated | Modulators of alpha-1 antitrypsin |
| JP7732999B2 (ja) | 2020-04-03 | 2025-09-02 | バーテックス ファーマシューティカルズ インコーポレイテッド | アルファ１－アンチトリプシンのモジュレーター |
| IL296920A (en) * | 2020-04-03 | 2022-12-01 | Vertex Pharma | Indole derivatives as alpha-1-antitrypsin modulators for the treatment of alpha-1-antitrypsin deficiency (aatd) |
| WO2022104353A1 (en) | 2020-11-12 | 2022-05-19 | Vertex Pharmaceuticals Incorporated | Methods of monitoring alpha-1 antitrypsin (aat) deficiency by measuring polymerised aat |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006019831A1 (en) * | 2004-07-14 | 2006-02-23 | Ptc Therapeutics, Inc. | Methods for treating hepatitis c |
| US8097644B2 (en) * | 2006-03-28 | 2012-01-17 | Allergan, Inc. | Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist |
| JP5107589B2 (ja) * | 2007-02-13 | 2012-12-26 | 旭化成株式会社 | インドール誘導体 |
| HUE025471T2 (hu) * | 2008-04-16 | 2016-03-29 | Karobio Ab | Új ösztrogén receptor ligandumok |
-
2021
- 2021-04-02 AU AU2021246104A patent/AU2021246104A1/en active Pending
- 2021-04-02 EP EP21732608.1A patent/EP4126817A1/en active Pending
- 2021-04-02 CA CA3177524A patent/CA3177524A1/en active Pending
- 2021-04-02 US US17/916,388 patent/US20230339915A1/en active Pending
- 2021-04-02 WO PCT/US2021/025591 patent/WO2021203007A1/en not_active Ceased
- 2021-04-02 JP JP2022559580A patent/JP7733670B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023520207A5 (enExample) | ||
| JP2021513967A5 (enExample) | ||
| JP2023500611A5 (enExample) | ||
| CA2133079C (en) | Oxazolidinone antimicrobials containing substituted diazine moieties | |
| JP2024050527A5 (enExample) | ||
| ES2377947T3 (es) | Compuestos de pirimidina como inhibidores de la interleucina 12 (IL-12) | |
| JP2021523221A5 (enExample) | ||
| JP2024521895A5 (enExample) | ||
| CA2359115A1 (en) | Acyl derivatives which treat vla-4 related disorders | |
| JP2010519304A5 (enExample) | ||
| JP2023539194A5 (enExample) | ||
| JP2012530703A5 (enExample) | ||
| RU2005116254A (ru) | Производные пиридопирролизина и пиридоиндолизина | |
| JP2020122016A5 (enExample) | ||
| CA2486537A1 (en) | 4-(substituted cycloalkylmethyl)imidazole-2-thiones, 4-(substituted cycloalkenylmethyl)imidazole-2-thiones, 4-(substituted cycloalkylmethyl)imidazol-2-ones and 4-(substituted cycloalkenylmethyl)imidazol-2-ones and related compounds | |
| JP2022544714A5 (enExample) | ||
| JP2931410B2 (ja) | 置換ベンズアミジン類、その製法及びそれらの医薬品としての使用 | |
| HUP0301562A2 (hu) | Új oxazolidinonszármazékok és eljárás ezek előállítására, ezeket tartalmazó gyógyszerkészítmények | |
| JP2002526501A5 (enExample) | ||
| JP2011523646A5 (enExample) | ||
| KR927003556A (ko) | 이방향족 치환된 aids 치료 화합물 | |
| JP2025505644A5 (enExample) | ||
| JP2021534097A5 (enExample) | ||
| JP2019507114A5 (enExample) | ||
| JP2025505200A5 (enExample) |